Evidence map›Paper›PMID 34572852›Full record

ArticleCancers2021

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial.

Irene A Caspers, Karolina Sikorska, Astrid E Slagter, Romy M van Amelsfoort, Elma Meershoek-Klein Kranenbarg, Cornelis J H van de Velde, Pehr Lind, Marianne Nordsmark, Edwin P M Jansen, Marcel Verheij and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00407186 (A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00407186 phase3unknown statusnot on this map

A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer (CRITICS Study)

TypeinterventionalSponsorDutch Colorectal Cancer GroupRan2007 to 2025Enrolled788ConditionsGastric CancerArmscisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Effect of preoperative chemotherapy on the histopathological classification of gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Irene A CaspersDepartment of Gastrointestinal Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0003-2073-4485
Karolina SikorskaDepartment of Biometrics, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Astrid E SlagterDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-3020-0180
Romy M van AmelsfoortDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Elma Meershoek-Klein KranenbargDepartment of Biometrics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-1750-2221
Cornelis J H van de VeldeDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Pehr LindDepartment of Oncology, Stockholm Söder Hospital, 118 83 Stockholm, Sweden.
Marianne NordsmarkDepartment of Medical Oncology, Aarhus University, 8200 Aarhus, Denmark.
Edwin P M JansenDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Marcel VerheijDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Johanna W van SandickDepartment of Surgery, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Annemieke CatsDepartment of Gastrointestinal Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Nicole C T van GriekenDepartment of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0001-9992-0760
The Netherlands Cancer Institute · NLLeiden University Medical Center · NLAarhus University · DKAmsterdam University Medical Centers · NLKarolinska Institutet · SERadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) patients at high risk of developing peritoneal metastasis (PM) as a single site of metastasis after curative treatment may be candidates for adjuvant prophylactic strategies. Here we investigated risk factors for metachronous isolated PM in patients who were treated in the CRITICS trial (NCT00407186). Univariable and multivariable analyses on both metachronous isolated PM and 'other events', i.e., (concurrent) distant metastasis, locoregional recurrence or death, were performed using a competing risk model and summarized by cumulative incidences. Isolated PM occurred in 64 of the 606 (11%) included patients. Diffuse or mixed histological subtype, ypT4 tumor stage and LN

Indexed as

gastric cancermetachronousmultimodality treatmentperitoneal metastasisrisk factors

Identifiers

PMID34572852
PMCPMC8469213
OpenAlexW3201346763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.